In 2022, Impiricus closed a $3 million Series Seed financing round led by FCA Venture Partners, with participation from Surface Ventures.

“Impiricus clearly fits our investment thesis,” said Todd Johnson, Partner at FCA Venture Partners. “A bold leadership team with a powerful product and the potential to reshape pharma-HCP collaboration.”

The funding supports our ongoing mission to transform healthcare communication by connecting physicians and pharma through real-time, ethical, AI-powered technology.